. Dr. Youssef is highly rated in 24 conditions, according to our data. Her top areas of expertise are Sepsis, Endocarditis, Pneumonia, and Cellulitis.

. Dr. Molony is highly rated in 7 conditions, according to our data. Her top areas of expertise are Osteomyelitis, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Harrys Torres is an Infectious Disease provider in Houston, Texas. Dr. Torres is highly rated in 6 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, and Hepatitis E.

. Dr. Patel is highly rated in 29 conditions, according to our data. His top areas of expertise are Infective Endocarditis, Hospital-Acquired Pneumonia, Lymphangitis, and Pneumonia.

Emily Blumberg is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Blumberg is highly rated in 19 conditions, according to our data. Her top areas of expertise are Cytomegalovirus Infection, Cytomegalic Inclusion Disease, HIV/AIDS, Kidney Transplant, and Liver Transplant. Dr. Blumberg is currently accepting new patients.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is highly rated in 12 conditions, according to our data. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Pablo Tebas is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Tebas is highly rated in 12 conditions, according to our data. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex. Dr. Tebas is currently accepting new patients.

Steven Gordon is an Infectious Disease provider in Cleveland, Ohio. Dr. Gordon has been practicing medicine for over 46 years is highly rated in 7 conditions, according to our data. His top areas of expertise are Infective Endocarditis, Endocarditis, Listeriosis, Thrombectomy, and Splenectomy.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is highly rated in 7 conditions, according to our data. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Timothy Flanigan is an Infectious Disease provider in Providence, Rhode Island. Dr. Flanigan is highly rated in 7 conditions, according to our data. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Myelitis.

Dr. Chanu Rhee is an infectious disease and critical care physician, Medical Director of Infection Control at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital followed by an infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and an MPH degree from the Harvard T.H. Chan School of Public Health. Dr. Rhee is internationally recognized for his expertise and contributions to the epidemiology, surveillance, diagnosis, and treatment of sepsis, particularly through the innovative use of electronic health record data to generate insights that inform clinical practice, quality improvement, and public health policy. His areas of focus also include infection prevention and control, antimicrobial resistance and stewardship, infections in immunocompromised patients, and the care of critically ill patients. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham healthcare system and has participated in many national committees focused on enhancing sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.Dr. Rhee attends clinically on the transplant / oncology infectious disease service and the Medical ICU at Brigham and Women’s Hospital. In his role as Medical Director of Infection Control, he leads institutional efforts to prevent healthcare-associated infections, investigate outbreaks, and advance patient safety. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine. He has served as principal or lead investigator on multiple federally funded grants, has authored over 200 peer-reviewed articles, and is recognized by ScholarGPS as one of the world’s most highly cited and influential experts on sepsis. Dr. Rhee is highly rated in 6 conditions, according to our data. His top areas of expertise are Sepsis, Severe Acute Respiratory Syndrome (SARS), Hospital-Acquired Pneumonia, and Pneumonia.

Jeanne Sheffield is an Infectious Disease specialist and a Neonatologist in Baltimore, Maryland. Dr. Sheffield is highly rated in 6 conditions, according to our data. Her top areas of expertise are Congenital Syphilis, Placenta Previa, Zika Virus Disease, Achalasia Microcephaly Syndrome, and Hysterectomy.

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School.  He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center.  Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is now the Harriet Ryan Albee Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital.  Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection.  He has chaired several multicenter studies of HIV therapy and previously chaired the AIDS Clinical Trials Group.  He has served on numerous NIH committees, including as a member of the NIH Office of AIDS Research Advisory Council.  He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors.  He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases.  His research interests focus on HIV therapeutics, antiretroviral drug resistance, HIV eradication and more recently, COVID-19. Dr. Kuritzkes is highly rated in 5 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Colleen Kraft is an Infectious Disease provider in Atlanta, Georgia. Dr. Kraft has been practicing medicine for over 24 years is highly rated in 5 conditions, according to our data. Her top areas of expertise are Ebola Virus Disease, Viral Hemorrhagic Fever, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Cataract Removal.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is highly rated in 5 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Dr. Andrea L. Cox is a professor of Internal Medicine at the Johns Hopkins University School of Medicine in the Division of Infectious Diseases and is a member of the Johns Hopkins Kimmel Cancer Center. She holds joint appointments in Oncology and at the Johns Hopkins Bloomberg School of Public Health, in Molecular Microbiology and Immunology. She is an internationally recognized leader in studies of immune responses in immunocompetent and immunocompromised patient populations to viral infections and vaccines against them, including SARS-Co-V-2 (the virus that causes COVID-19), HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Dr. Cox earned her Ph.D. in chemistry from the University of Virginia, where she characterized peptides that drive T cell responses. She then earned her M.D. and completed internal medicine residency and infectious disease fellowship training at Johns Hopkins. She leads the largest prospective cohort study of acute HCV infection, designed to enable detailed molecular analysis of HCV transmission, host immune responses, and virus sequence evolution. She co-led the first prophylactic HCV vaccine trial in individuals at risk of HCV infection. She leads a multidisciplinary international team investigating HCV-specific immune responses to improve vaccine development against HCV, is the lead immunologist on a clinical trial of HBV vaccines in people living with HIV, and co-leads a large team investigating immune responses to COVID-19 infection and vaccines. In addition to her research on viral infections and vaccines, Dr. Cox is actively involved in clinical care of patients with HCV, HIV, and HBV infections. Dr. Cox serves as the director of the Medical Scientist Training Program. A teacher, advisor, and mentor of physician-scientists and scientists, Dr. Cox mentors Ph.D. students in the Johns Hopkins Cellular and Molecular Medicine, Molecular Microbiology and Immunology, and the Immunology graduate training programs. Dr. Cox is highly rated in 5 conditions, according to our data. Her top areas of expertise are Hepatitis C, Hepatitis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Pamela Warnick is an Infectious Disease provider in Chicago, Illinois. Dr. Warnick is highly rated in 5 conditions, according to our data. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and HIV/AIDS.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is highly rated in 4 conditions, according to our data. His top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and Sepsis.

As both a practicing physician and a research scientist, I have cultivated a particular interest in medical mycology. Her research focuses on the identification of virulence factors and the interaction of several fungi with the human host. Her goal is to identify and characterize regulatory mechanisms at a post-transcriptional level that have a crucial role in the development of Valley Fever in humans. Dr. Donovan is highly rated in 4 conditions, according to our data. Her top areas of expertise are Coccidioidomycosis, Leishmaniasis, Meningitis, Pneumonia, and Endoscopy.

I enjoy spending time with friends and family. Dr. Marschall is highly rated in 4 conditions, according to our data. His top areas of expertise are Asymptomatic Bacteriuria, Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Hip Replacement, and Knee Replacement.

Tennis, jazz music and UA basketball. Dr. Galgiani is highly rated in 3 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Blastomycosis, Pneumonia, and Meningitis.

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is highly rated in 3 conditions, according to our data. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis.

Our primary research interest is in the biology, pathogenesis and immunology of Plasmodium falciparum. Patients infected with this parasite can be completely asymptomatic or develop severe disease resulting in death. The goal of our research has been to define the molecular mechanisms that underlie this variation in disease outcomes in P. falciparum. Toward this goal, we have developed a new pathogenesis model through the analysis of in vivo parasite biology and associated host factors using a whole genome and metabolomic approach. We have identified novel parasite biology when it resides in the human host and idnetified a putative mediator of coma in cerebral malaria.  We also are studying adjunctive therapy to improve outcomes in severe malaria using the animal model.   We carry out field based translational studies in cohorts infected with malaria in Africa and test hypothesis in the animal model of malaria.  The long term goal is to identify parasite and host processes involved in disease to serve as targets for vaccine or chemotherapeutic development. Dr. Daily is highly rated in 3 conditions, according to our data. Her top areas of expertise are Primary Amebic Meningoencephalitis, Malaria, Togaviridae Disease, Severe Acute Respiratory Syndrome (SARS), and Leg or Foot Amputation.

Dr. Lichterfeld is an infectious disease physician at BWH and an Associate Professor at HMS. He is also an Associate Member of the Ragon Institute and of the Broad Institute of MIT and Harvard. He received his medical degree from the University of Heidelberg, Germany and completed his residency at Massachusetts General Hospital. In 2008-2011, he was an infectious disease fellow at the Brigham and Women’s Hospital and at Massachusetts General Hospital, with Dr. Eric Rosenberg as his mentor. He is a member of the American Association for Clinical Investigation, a fellow of the Infectious Disease Society of America, and has served as a chartered member of several study sections at the National Institutes of Health.Dr. Lichterfeld’s research interests focus on retroviral infections, specifically on HIV-1. His laboratory explores how HIV-1 can persist in the human body for a lifetime, despite very effective antiretroviral therapy that is available now; these studies involve a platform of recently-developed new technologies for single-cell profiling of virally-infected cells. Dr. Lichterfeld also leads clinical trials in which novel therapeutic approaches for HIV eradication and cure are evaluated; several of these studies are currently enrolling new patients. In collaboration with investigators from the Harvard School of Public Health, Dr. Lichterfeld’s lab also participates as a co-investigator in clinical trials with HIV-1-infected infants from Botswana. Dr. Lichterfeld is highly rated in 2 conditions, according to our data. His top areas of expertise are HIV/AIDS, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Hepatitis.